Key facts
- This page summarizes Stefan Vitorovic's Form 4 filing for Praxis Precision Medicines, Inc. (PRAX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 27 May 2022, 17:27.
Stefan Vitorovic - 26 May 2022 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)
- Reporting relationship
- Director
- Issuer ticker
- PRAX
- Reported as of
- 26 May 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 27 May 2022, 17:27:03 UTC
- Prior SEC filing
- 11 Jan 2022
- Next SEC filing
- 13 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alex Nemiroff, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stefan Vitorovic filed Form 4 for Praxis Precision Medicines, Inc. (PRAX) on 27 May 2022.
Change
- Previous filing in this sequence was filed on 11 Jan 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PRAX
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +22,753
- Change %
- Price
- $0.000000
- Shares after
- 22,753
- Date
- 26 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 22,753
- Exercise price
- $8.38
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on May 26, 2022.